1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Chen Lijuan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma Aspirin, Rivaroxaban - Multiple Myeloma, Venous Thromboembolism (VTE) | Phase 4 | Recruiting | Chen Lijuan | 200 | 2024-02-01 | 2026-10-30 |
Multiple Myeloma (1) · Venous Thromboembolism (1)
Aspirin (1) · Rivaroxaban (1)
China (1)